Total Payments
$1,956
2024 Payments
$478.40
Companies
19
Transactions
57
Medicare Patients
4,796
Medicare Billing
$648,863
Payment Breakdown by Category
Food & Beverage$1,794 (91.7%)
Education$162.26 (8.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,794 | 52 | 91.7% |
| Education | $162.26 | 5 | 8.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $469.78 | 6 | $0 (2017) |
| Astellas Pharma US Inc | $368.90 | 16 | $0 (2023) |
| Janssen Biotech, Inc. | $162.43 | 3 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $153.66 | 3 | $0 (2024) |
| KARL STORZ Endoscopy-America | $126.15 | 1 | $0 (2019) |
| PFIZER INC. | $114.35 | 7 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $97.12 | 2 | $0 (2024) |
| Allergan, Inc. | $92.50 | 5 | $0 (2022) |
| Blue Earth Diagnostics Limited | $65.47 | 3 | $0 (2018) |
| ABBVIE INC. | $52.66 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.40 | 11 | Janssen Biotech, Inc. ($162.43) |
| 2023 | $50.12 | 2 | AbbVie Inc. ($25.46) |
| 2022 | $240.72 | 9 | Astellas Pharma US Inc ($62.20) |
| 2021 | $67.90 | 4 | Astellas Pharma US Inc ($49.63) |
| 2019 | $374.90 | 12 | Astellas Pharma US Inc ($130.43) |
| 2018 | $183.50 | 10 | Blue Earth Diagnostics Limited ($65.47) |
| 2017 | $560.59 | 9 | OPKO Pharmaceuticals, LLC ($469.78) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Urology | ||||||
| 10/16/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $110.99 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $73.04 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/16/2024 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: Oncology | ||||||
| 06/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: UROLOGY | ||||||
| 03/29/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Urology | ||||||
| 07/13/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/02/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Education | In-kind items and services | $12.01 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/15/2022 | Antares Pharma, Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $43.78 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 05/14/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $43.16 | General |
| Category: Oncology | ||||||
| 05/14/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $37.34 | General |
| Category: Oncology | ||||||
| 04/26/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Urology | ||||||
| 02/09/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/02/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 01/12/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/15/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ONCOLOGY | ||||||
| 05/26/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ONCOLOGY | ||||||
| 05/12/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,110 | 1,467 | $503,315 | $147,632 |
| 2022 | 9 | 1,171 | 1,518 | $608,409 | $161,800 |
| 2021 | 10 | 1,304 | 1,749 | $728,341 | $193,084 |
| 2020 | 11 | 1,211 | 1,598 | $594,899 | $146,347 |
Total Patients
4,796
Total Services
6,332
Medicare Billing
$648,863
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 673 | 997 | $281,692 | $91,769 | 32.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 106 | 118 | $110,912 | $22,345 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 149 | 149 | $47,127 | $18,212 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 137 | $27,882 | $9,117 | 32.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 12 | 12 | $10,155 | $2,311 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $5,974 | $1,942 | 32.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 18 | 18 | $15,233 | $1,623 | 10.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 12 | 12 | $4,340 | $311.16 | 7.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 687 | 975 | $275,477 | $91,171 | 33.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 84 | 96 | $90,233 | $18,777 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 134 | 134 | $42,383 | $16,525 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 179 | 224 | $45,588 | $15,345 | 33.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2022 | 13 | 15 | $68,652 | $6,901 | 10.1% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 11 | 11 | $49,588 | $6,368 | 12.8% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 16 | 16 | $13,540 | $3,273 | 24.2% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 16 | 16 | $13,540 | $1,554 | 11.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,982 | $1,486 | 37.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 15 | 15 | $5,425 | $400.71 | 7.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 728 | 1,116 | $315,315 | $107,967 | 34.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 173 | 173 | $54,718 | $20,733 | 37.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 92 | 105 | $98,693 | $19,889 | 20.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 181 | 221 | $44,978 | $15,169 | 33.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2021 | 16 | 19 | $86,960 | $8,885 | 10.2% |
| 52601 | Electro-removal of prostate through bladder canal (urethra) with control of bleeding using an endoscope | Facility | 2021 | 12 | 12 | $54,096 | $7,076 | 13.1% |
| 55700 | Biopsy of prostate gland | Office | 2021 | 22 | 22 | $18,618 | $4,401 | 23.6% |
About Dr. Stephen Zappala, M.D
Dr. Stephen Zappala, M.D is a Specialist healthcare provider based in Andover, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215953039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Zappala, M.D has received a total of $1,956 in payments from pharmaceutical and medical device companies, with $478.40 received in 2024. These payments were reported across 57 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,794).
As a Medicare-enrolled provider, Zappala has provided services to 4,796 Medicare beneficiaries, totaling 6,332 services with total Medicare billing of $648,863. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Andover, MA
- Active Since 07/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215953039
Products in Payments
- Rayaldee (Drug) $469.78
- XTANDI (Drug) $305.71
- ERLEADA (Drug) $162.43
- ADSTILADRIN (Biological) $153.66
- BOTOX (Biological) $132.24
- 09 PROMO FLEX-X FLEX URETEROSCOPE, 7.5F (Device) $126.15
- PYLARIFY (Drug) $97.12
- Myrbetriq (Drug) $84.65
- Axumin (Drug) $65.47
- NOCDURNA (Drug) $43.78
- Xtandi (Drug) $43.16
- Da Vinci Surgical System (Device) $40.00
- OPDIVO (Biological) $37.34
- TOVIAZ (Drug) $28.73
- ORGOVYX (Drug) $21.00
- Stravix (Biological) $19.78
- Axonics (Device) $18.80
- GENERAL BPH (Device) $18.17
- FMS (Device) $13.37
- BOTOX THERAPEUTIC (Biological) $12.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Andover
Victor Villarreal, M.d, M.D
Specialist — Payments: $3,660
Specialist $3,660
Dr. Margaret Downes, Ed.d, ED.D
Specialist
Specialist
Dr. Mark Winholtz
Specialist
Specialist
Stephen Amos, Phd, PHD
Specialist
Specialist
Mrs. Cynthia Mckallagat, Cfm, CFM
Specialist
Specialist
Karen Sathre
Specialist
Specialist